2012 Researcher Paula Foster

In Vivo MRI Characterization of Changing Blood-Tumour Barrier Permeability in a Mouse Model of Brain Metastasis

brain tumour researcher paula foster


Paula Foster
Robarts Research Institute: London, Ontario
Award: $23,500.00

What does the title mean?

This research focuses on the cells responsible for blocking treatment to the brain, specifically multi-drug resistant glioblastoma multiforme

Project Summary:

The most common tumours in the central nervous system are metastases originating from lung and breast cancer. Brain metastasis occurs in 15-25% of metastatic breast cancer patients. A diagnosis of brain metastases is terrifying. Untreated, the median survival time is 2–3 months; aggressive treatment extends this only marginally, to 4–12 months.

The blood brain barrier (BBB) tightly controls the passage of substrates from the blood into the brain and this hinders delivery of chemotherapeutics to metastatic tumours in the brain. When tumours develop the local BBB, sometimes referred to as the blood-tumor-barrier (BTB), can become leaky (or permeable). However, not all tumours are permeable. Within one individual there can exist both permeable and non-permeable tumours. This makes treatment very complicated.

In this project we are using a mouse model of breast cancer metastasis to the brain and advanced MRI tools to detect and monitor the leakiness of brain tumours over time in the whole brain. We expect our research will produce important information about what influences tumour growth and permeability in the brain. It is critical to understand the conditions that cause altered and heterogeneous BBB permeability in order to advance the development of treatments for brain tumours.

Final Report:

Radiotherapy of the whole head is the standard of care for breast cancer patients with multiple brain lesions. While this treatment has been essential in the management of existing tumours, there are also many known negative effects associated with radiation of normal brain. In this study MRI was used to examine how radiotherapy of normal brain can effect the likelihood of growth of new tumours in an animal model of breast cancer brain metastasis. Imaging results showed that irradiated but otherwise healthy brain had an increased ability to support the growth of cancer. Investigating the impact of radiotherapy on normal brain could have implications in clinical patient management, particularly in patients with brain cancer that is resistant to radiotherapy or pre-exisiting cancer elsewhere in the body. Read more in this publication...
 

Share This

Featured Story

Childhood Brain Tumour Signs & Symptoms

Earlier this year, you gave us your feedback in a survey on brain tumour signs and symptoms. One of the things we did with that survey was to compile a list of the most common signs & symptoms for children. Now, as part of Childhood Cancer Awareness Month, we are sharing compelling quotes from that survey and urging you to share them with this link to see the symptoms: www.braintumour.ca/symptoms. Thank you!

Learn more

Spotlight

Anthony's Story is Our Story

I would like to take the opportunity to share "our" story. It’s actually my best friend Anthony's story, but I use the term "our"...

Learn more

Kate's Mum's Story

"May 2006 is a month I will never forget. That was the moment that everything became before the cancer, and after the cancer. It was a...

Learn more

Upcoming Events

  • 16/Oct/2018: North Bay Support Group: Meets at St. Luke's Catholic Elementary School, 225 Milani Road, North Bay.... Learn more >
  • 16/Oct/2018: Groupe de soutien virtuel: Un groupe de soutien virtuel pour personnes touchées par une tumeur... Learn more >
  • 16/Oct/2018: New Glasgow Support Group: Meets at East Haven Manor, 695 East River Road in New Glasgow, NS ... Learn more >
  • 17/Oct/2018: Windsor Support Group: Meets at the United Way, Unit A1, 300 Giles Blvd. East... Learn more >
View All Events >
Thank you to the donors whose contributions make this website and all programs, services and research possible.

Copyright © 2018 Brain Tumour Foundation of Canada. Charitable Registration #BN118816339RR0001